thioctic acid has been researched along with Drug-Related Side Effects and Adverse Reactions in 4 studies
Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
Drug-Related Side Effects and Adverse Reactions: Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
Excerpt | Relevance | Reference |
---|---|---|
"Malondialdehyde was increased as an indicator of free radical formation in AK-induced group and decreased with ALA treatment." | 1.42 | The impact of alpha-lipoic acid on amikacin-induced nephrotoxicity. ( Asci, H; Bayram, D; Candan, IA; Cankara, FN; Ilhan, I; Saygin, M; Yesilot, S, 2015) |
" ALA was not acutely toxic to rats (LD(50)>2000mg/kg bw, OECD method 425)." | 1.33 | Safety evaluation of alpha-lipoic acid (ALA). ( Cremer, DR; Lynch, B; Rabeler, R; Roberts, A, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asci, H | 1 |
Saygin, M | 1 |
Cankara, FN | 1 |
Bayram, D | 1 |
Yesilot, S | 1 |
Candan, IA | 1 |
Ilhan, I | 1 |
DE BENEDICTIS, G | 1 |
CACUDI, G | 1 |
Cremer, DR | 1 |
Rabeler, R | 1 |
Roberts, A | 1 |
Lynch, B | 1 |
Coleman, MD | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Dose Finding and Tolerability Study of Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Peripheral Neuropathy[NCT01313117] | Phase 1/Phase 2 | 9 participants (Actual) | Interventional | 2012-02-29 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
(NCT01313117)
Timeframe: 4 months
Intervention | participants (Number) |
---|---|
Alpha Lipoic Acid | 9 |
Based on acceptable adverse event (AE) profile and continual reassessment method dose escalation. (NCT01313117)
Timeframe: 4 months
Intervention | mg (Number) |
---|---|
Alpha Lipoic Acid | 500 |
(NCT01313117)
Timeframe: 4 months
Intervention | participants (Number) |
---|---|
Alpha Lipoic Acid | 7 |
4 other studies available for thioctic acid and Drug-Related Side Effects and Adverse Reactions
Article | Year |
---|---|
The impact of alpha-lipoic acid on amikacin-induced nephrotoxicity.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Blood Urea Nitrogen; Creatinine; Disease Mod | 2015 |
[Experimental research on the possible protective action of thioctic acid in acute isonicotinic acid hydrazide poisoning. II].
Topics: Drug-Related Side Effects and Adverse Reactions; Isoniazid; Thioctic Acid; Vitamin A; Vitamin K; Vit | 1959 |
Safety evaluation of alpha-lipoic acid (ALA).
Topics: Animals; Antioxidants; Behavior, Animal; Body Weight; Drug-Related Side Effects and Adverse Reaction | 2006 |
Improvement of patient tolerance to dapsone: current and future developments.
Topics: Antioxidants; Cimetidine; Dapsone; Dermatologic Agents; Drug-Related Side Effects and Adverse Reacti | 2007 |